论文部分内容阅读
脑出血死亡率甚高,迄今尚无有效疗法.我院试用量子血液疗法治疗25例急性脑出血,取得一定疗效,现报告如下:资料与方法选近1年来住院脑出血患者55例,随机分为观察组(用量子血疗)和对照组(未用量子血疗).观察组男15例,女10例,平均年龄58.4岁.对照组男18例,女12例,平均年龄59.6岁,两组均符合第二届全国脑血管病学术会议诊断要点,并经腰穿或头颅CT证实.观察组常规治疗加量子血液疗法,即采患者静脉血200ml注入含ACD液的石英容器内,混匀后将该容器置于治疗仪内,同时经紫外线照射和充氧8～10分后再回输给患者.三日一次,5次为一疗程.对照组单用常规治疗.两组病程1～10天.
The mortality rate of cerebral hemorrhage is very high, so far there is no effective therapy.Our hospital trial of quantum hematotherapy for 25 cases of acute cerebral hemorrhage, achieved a certain effect, are as follows: Materials and Methods In recent 1 years 55 cases of hospitalized patients with cerebral hemorrhage randomized The observation group (with quantum blood treatment) and the control group (without quantum blood treatment) .The observation group of 15 males and 10 females, mean age 58.4 years.The control group of 18 males and 12 females, mean age 59.6 years old, Both groups were in line with the Second National Conference on cerebrovascular disease diagnosis, and confirmed by lumbar puncture or cranial CT observation group conventional treatment plus quantum hematotherapy, that is, the patient venous blood 200ml into the quartz container containing ACD fluid, mixed After the container was placed in the treatment instrument evenly, at the same time after UV irradiation and oxygenation 8 ~ 10 points and then returned to the patient once every three days, 5 times for a course of treatment in the control group alone conventional treatment duration of 1 ~ 10 days.